Digital Minds, Analog Laws: A Comparative Study of Regulatory Frameworks Governing Mental Health Telemedicine in India, the US, and the UK

India faces a mental health crisis of staggering proportions, with an estimated 83% treatment gap and fewer than 0.3 psychiatrists per 100,000 population. Telemedicine has emerged as a transformative mechanism for bridging this gap, as evidenced by the Tele-MANAS programme's reach to over two million callers, 35% of whom were first-time mental health seekers. However, India's regulatory framework creates significant legal barriers to tele-psychiatry and digital mental health service delivery. This article undertakes a comparative legal analysis of mental health telemedicine regulation across three jurisdictions: India, the United States, and the United Kingdom. The analysis examines five regulatory dimensions: prescribing restrictions for controlled substances, informed consent standards, licensure and cross-jurisdictional practice, quality assurance and accreditation, and data protection for mental health records. The article argues that the Telemedicine Practice Guidelines 2020's blanket List B prohibition on psychotropic medications, the Mental Healthcare Act 2017's silence on telemedicine-based service delivery, and the absence of tele-psychiatry-specific informed consent standards collectively constitute a regulatory architecture that is fundamentally misaligned with the constitutional right to mental healthcare. Drawing on the US and UK models, the article proposes specific legislative and regulatory reforms, including amendments to the TPG 2020's prescribing restrictions, explicit integration of telemedicine within the Mental Healthcare Act framework, and the development of national tele-psychiatry practice standards.